During a 38-month period, we studied 320 liver transplants in 283 recipients (202 adults, 81
children). CMV disease was documented in 85 patients (30.0%). The major risk factor for …

BACKGROUND: Cytomegalovirus (CMV) infection and related disease is a feared
complication after liver transplantation. Antiviral prophylaxis is recommended in clinical …

Background The role of secondary cytomegalovirus (CMV) prophylaxis, defined as the
continuation of valganciclovir to prevent relapse after the successful treatment of CMV …

Cytomegalovirus (CMV) infection is an opportunistic infection frequently found after solid
organ transplantation, and it contributes significantly to mortality and morbidity. CMV …

Background. We conducted a trial of long-term ganciclovir prophylaxis for prevention of
primary cytomegalovirus (CMV) disease in CMV-seronegative liver transplant recipients with …

BACKGROUND: Cytomegalovirus (CMV) infections are among the most common infections
following liver transplantation. The main preventive methods for CMV infections are …

It is believed that antiviral prophylaxis decreases the incidence of cytomegalovirus (CMV)
reactivation and disease. There are few data regarding weekly assays for CMV DNA after …

As cytomegalovirus (CMV) disease was a leading cause of death following liver
transplantation in earlier reports, general CMV prophylaxis is widely used. We re‐evaluated …

Cytomegalovirus is the single most important pathogen in clinical transplantation. Although
much progress has been made in our understanding of the molecular biology and …

Cytomegalovirus (CMV) remains a major cause of problems following solid organ
transplantation, accounting for a significant increase in morbidity and affiliated costs …